BSX · News · 20261104N

Acquisition / Partnership / Divestiture

BOSTON SCIENTIFIC CORP · 2026-11-04 · Importance 52 · Surprise 42

Boston Scientific agreed to a co-funding partnership with Blackstone Life Sciences to develop VITALYST, a next-generation heart pump for cardiogenic shock. The report describes the deal as securing $455 million for the project. It is the first medical technology project jointly financed by Boston Scientific and Blackstone Life Sciences.

Key facts

• Boston Scientific agreed a co-funding partnership with Blackstone Life Sciences to develop the VITALYST next-generation heart pump for cardiogenic shock. source
• The VITALYST project is the first time Boston Scientific and Blackstone Life Sciences have jointly financed a medical technology project. source